Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · IEX Real-Time Price · USD
5.10
-0.01 (-0.20%)
At close: Jul 19, 2024, 4:00 PM
5.05
-0.05 (-0.98%)
Pre-market: Jul 22, 2024, 7:09 AM EDT
Company Description
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.
It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone.
The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies, Inc.
Country | United States |
Founded | 1996 |
IPO Date | Feb 13, 2014 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 43 |
CEO | Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. |
Contact Details
Address: 1885 West 2100 Street Salt Lake City, Utah 84119 United States | |
Phone | 801-839-3516 |
Website | sintx.com |
Stock Details
Ticker Symbol | SINT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001269026 |
CUSIP Number | 829392307 |
ISIN Number | US8293926049 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. | Chief Executive Officer, President, Principal Financial Officer and Chairman |
David Francis O'Brien | Executive Vice President and Chief Operating Officer |
Michael Marcroft | Vice President of Sales and Marketing |
Gina Moss | Director of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 11, 2024 | 8-K | Current Report |
Jul 11, 2024 | 424B5 | Filing |
Jun 12, 2024 | 8-K | Current Report |
May 23, 2024 | 8-K | Current Report |
May 15, 2024 | 8-K | Current Report |
May 13, 2024 | 10-Q | Quarterly Report |
Apr 30, 2024 | 8-K | Current Report |
Apr 16, 2024 | DEFN14A | Filing |
Apr 12, 2024 | 8-K | Current Report |
Apr 5, 2024 | PRE 14A | Other preliminary proxy statements |